Members of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 Diabetes, taking us from clinical trials to clinical practice.
Members of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 Diabetes, taking us from clinical trials to clinical practice.